This study aims to determine the most effective and clinically meaningful cut-off values for p53, Ki-67, and E-cadherin to differentiate NMIBC from MIBC and to differentiate tumor grades within current urothelial carcinoma classification systems. Here, TP53 is linked to urothelial carcinoma.